Author: GlobeNewswire

SALINAS, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Lowell Farms Inc. (“Lowell Farms” or the “Company”) (CSE:LOWL; OTCQX:LOWLF), a leading,…

Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 23, 2023 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical…

PRESS RELEASE ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes Lyon (France), May…

FORT WORTH, Texas, May 23, 2023 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing…

WALTHAM, Mass., May 23, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover,…

SOUTH SAN FRANCISCO, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative…

BOSTON, May 23, 2023 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”) confirmed that it has received an unsolicited…

FLORHAM PARK, N.J., May 23, 2023 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…

This article or press release has no online content. Please download the associated documents for more information.   Attachment Share-buyback-program-Ipsen-reporting-from-05-to-09-July-2021-Detailled

PRINCETON, N.J., May 22, 2023 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women’s…